Report Overview
Report Summary
Eternity Insights has published a new study on Global Human Coagulation Factor VII Market focusing on key segments as by Type (Recombinant Factor VIII,Plasma-derived Factor VIII, Other), by Application (Hemophilia A,Spontanous / Trauma,Surgical,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Human Coagulation Factor VII Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Human Coagulation Factor VII Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Human Coagulation Factor VII Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Human Coagulation Factor VII Market Segmentation:
Human Coagulation Factor VII Market, By Type
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Other
Human Coagulation Factor VII Market, By Application
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Human Coagulation Factor VII market in terms of demand generation. The Human Coagulation Factor VII market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Human Coagulation Factor VII market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Human Coagulation Factor VII Market Taxonomy:
To learn more about this report
Global Human Coagulation Factor VII Market Competitive Landscape
The global Human Coagulation Factor VII market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Recombinant Factor VIII,Plasma-derived Factor VIII, Other |
| By Application Outlook |
Hemophilia A,Spontanous / Trauma,Surgical,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Shire (Baxter),Bayer,CSL,Pfizer,Grifols,Biogen,Octapharma,NovoNordisk,Greencross,Kedrion,BPL,Hualan Bio,RAAS |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table Of Contents
Table of Contents
Global Human Coagulation Factor VII Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Human Coagulation Factor VII Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Human Coagulation Factor VII Industry Overview
2.1 Global Human Coagulation Factor VII Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Human Coagulation Factor VII Global Import Market Analysis
2.1.2 Human Coagulation Factor VII Global Export Market Analysis
2.1.3 Human Coagulation Factor VII Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Recombinant Factor VIII
2.2.2 Plasma-derived Factor VIII
2.3.2 Spontanous / Trauma
2.3.3 Surgical
2.3.4 Other
2.4.2 Global Human Coagulation Factor VII Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Human Coagulation Factor VII Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Human Coagulation Factor VII Manufacturer Market Share
2.4.5 Top 10 Human Coagulation Factor VII Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Human Coagulation Factor VII Market
2.4.7 Key Manufacturers Human Coagulation Factor VII Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Human Coagulation Factor VII Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Human Coagulation Factor VII Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Human Coagulation Factor VII Market Size Categorized by Regions
4.1 Global Human Coagulation Factor VII Revenue, Sales and Market Share by Regions
4.1.1 Global Human Coagulation Factor VII Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Coagulation Factor VII Revenue and Market Share by Regions (2015-2020)
4.2 Europe Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
4.3 APAC Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
4.4 North America Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
4.5 South America Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5 Europe Human Coagulation Factor VII Market Size Categorized by Countries
5.1 Europe Human Coagulation Factor VII Sales, Revenue and Market Share by Countries
5.1.1 Europe Human Coagulation Factor VII Sales by Countries (2015-2020)
5.1.2 Europe Human Coagulation Factor VII Revenue by Countries (2015-2020)
5.1.3 Germany Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5.1.4 UK Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5.1.5 France Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5.1.6 Russia Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5.1.7 Italy Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5.1.8 Spain Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
5.2 Europe Human Coagulation Factor VII Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Human Coagulation Factor VII Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Human Coagulation Factor VII Sales Market Share by Type (2015-2020)
5.3.2 Europe Human Coagulation Factor VII Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Human Coagulation Factor VII Sales Market Share by Application (2015-2020)
6 Asia-Pacific Human Coagulation Factor VII Market Size Categorized by Countries
6.1 Asia-Pacific Human Coagulation Factor VII Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Human Coagulation Factor VII Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Human Coagulation Factor VII Revenue by Countries (2015-2020)
6.1.3 China Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
6.1.4 Japan Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
6.1.5 Korea Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
6.1.6 India Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
6.1.8 Australia Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Human Coagulation Factor VII Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Human Coagulation Factor VII Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Human Coagulation Factor VII Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Human Coagulation Factor VII Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Human Coagulation Factor VII Sales and Market Share by Application (2015-2020)
7 North America Human Coagulation Factor VII Market Size Categorized by Countries
7.1 North America Human Coagulation Factor VII Sales, Revenue and Market Share by Countries
7.1.1 North America Human Coagulation Factor VII Sales by Countries (2015-2020)
7.1.2 North America Human Coagulation Factor VII Revenue by Countries (2015-2020)
7.1.3 United States Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
7.1.4 Canada Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
7.1.5 Mexico Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
7.2 North America Human Coagulation Factor VII Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Human Coagulation Factor VII Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Human Coagulation Factor VII Sales Market Share by Type (2015-2020)
7.3.2 North America Human Coagulation Factor VII Revenue and Revenue Share by Type (2015-2020)
7.4 North America Human Coagulation Factor VII Sales Market Share by Application (2015-2020)
8 South America Human Coagulation Factor VII Market Size Categorized by Countries
8.1 South America Human Coagulation Factor VII Sales, Revenue and Market Share by Countries
8.1.1 South America Human Coagulation Factor VII Sales by Countries (2015-2020)
8.1.2 South America Human Coagulation Factor VII Revenue by Countries (2015-2020)
8.1.3 Brazil Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
8.2 South America Human Coagulation Factor VII Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Human Coagulation Factor VII Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Human Coagulation Factor VII Sales Market Share by Type (2015-2020)
8.3.2 South America Human Coagulation Factor VII Revenue and Revenue Share by Type (2015-2020)
8.4 South America Human Coagulation Factor VII Sales Market Share by Application (2015-2020)
9 Middle East and Africa Human Coagulation Factor VII Market Size Categorized by Countries
9.1 Middle East and Africa Human Coagulation Factor VII Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Coagulation Factor VII Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Human Coagulation Factor VII Revenue by Countries (2015-2020)
9.1.3 GCC Countries Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
9.1.4 Turkey Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
9.1.5 Egypt Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
9.1.6 South Africa Human Coagulation Factor VII Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Human Coagulation Factor VII Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Human Coagulation Factor VII Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Human Coagulation Factor VII Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Human Coagulation Factor VII Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Human Coagulation Factor VII Sales Market Share by Application (2015-2020)
10 Global Human Coagulation Factor VII Market Segment by Type
10.1 Global Human Coagulation Factor VII Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Human Coagulation Factor VII Sales and Market Share by Type (2015-2020)
10.1.2 Global Human Coagulation Factor VII Revenue and Market Share by Type (2015-2020)
10.2 Recombinant Factor VIII Sales Growth Rate and Price
10.2.1 Global Recombinant Factor VIII Sales Growth Rate (2015-2020)
10.2.2 Global Recombinant Factor VIII Price (2015-2020)
10.3 Plasma-derived Factor VIII Sales Growth Rate and Price
10.3.1 Global Plasma-derived Factor VIII Sales Growth Rate (2015-2020)
10.3.2 Global Plasma-derived Factor VIII Price (2015-2020)
11.1 Global Human Coagulation Factor VIISales Market Share by Application (2015-2020)
11.2 Hemophilia A Sales Growth Rate (2015-2020)
11.3 Spontanous / Trauma Sales Growth Rate (2015-2020)
11.4 Surgical Sales Growth Rate (2015-2020)
11.5 Other Sales Growth Rate (2015-2020)
12.1 Global Human Coagulation Factor VII Revenue, Sales and Growth Rate (2020-2027)
12.2 Human Coagulation Factor VII Market Forecast by Regions (2020-2027)
12.2.1 Europe Human Coagulation Factor VII Market Forecast (2020-2027)
12.2.2 APAC Human Coagulation Factor VII Market Forecast (2020-2027)
12.2.3 North America Human Coagulation Factor VII Market Forecast (2020-2027)
12.2.4 South America Human Coagulation Factor VII Market Forecast (2020-2027)
12.2.5 Middle East & Africa Human Coagulation Factor VII Market Forecast (2020-2027)
12.3 Human Coagulation Factor VII Market Forecast by Type (2020-2027)
12.3.1 Global Human Coagulation Factor VII Sales Forecast by Type (2020-2027)
12.3.2 Global Human Coagulation Factor VII Market Share Forecast by Type (2020-2027)
12.4 Human Coagulation Factor VII Market Forecast by Application (2020-2027)
12.4.1 Global Human Coagulation Factor VII Sales Forecast by Application (2020-2027)
12.4.2 Global Human Coagulation Factor VII Market Share Forecast by Application (2020-2027)
13 Analysis of Human Coagulation Factor VII Industry Key Manufacturers
13.1 Shire (Baxter)
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Shire (Baxter) Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Shire (Baxter) News
13.2 Bayer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Bayer Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Bayer News
13.3 CSL
13.3.1 Company Details
13.3.2 Product Information
13.3.3 CSL Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 CSL News
13.4 Pfizer
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Pfizer Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Pfizer News
13.5 Grifols
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Grifols Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Grifols News
13.6 Biogen
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Biogen Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Biogen News
13.7 Octapharma
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Octapharma Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Octapharma News
13.8 NovoNordisk
13.8.1 Company Details
13.8.2 Product Information
13.8.3 NovoNordisk Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 NovoNordisk News
13.9 Greencross
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Greencross Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Greencross News
13.10 Kedrion
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Kedrion Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Kedrion News
13.11 BPL
13.11.1 Company Details
13.11.2 Product Information
13.11.3 BPL Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 BPL News
13.12 Hualan Bio
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Hualan Bio Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Hualan Bio News
13.13 RAAS
13.13.1 Company Details
13.13.2 Product Information
13.13.3 RAAS Human Coagulation Factor VII Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 RAAS News
15 Appendix